These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20738245)

  • 1. Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.
    Pirotte B; Francotte P; Goffin E; Fraikin P; Danober L; Lesur B; Botez I; Caignard DH; Lestage P; de Tullio P
    Curr Med Chem; 2010; 17(30):3575-82. PubMed ID: 20738245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor positive allosteric modulators: a patent review.
    Pirotte B; Francotte P; Goffin E; de Tullio P
    Expert Opin Ther Pat; 2013 May; 23(5):615-28. PubMed ID: 23405869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of novel AMPA potentiators.
    Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders.
    Reuillon T; Ward SE; Beswick P
    Curr Top Med Chem; 2016; 16(29):3536-3565. PubMed ID: 27363568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors.
    Francotte P; Goffin E; Fraikin P; Graindorge E; Lestage P; Danober L; Challal S; Rogez N; Nosjean O; Caignard DH; Pirotte B; de Tullio P
    J Med Chem; 2013 Oct; 56(20):7838-50. PubMed ID: 24090223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring thienothiadiazine dioxides as isosteric analogues of benzo- and pyridothiadiazine dioxides in the search of new AMPA and kainate receptor positive allosteric modulators.
    Francotte P; Bay Y; Goffin E; Colson T; Lesenfants C; Dorosz J; Laulumaa S; Fraikin P; de Tullio P; Beaufour C; Botez I; Pickering DS; Frydenvang K; Danober L; Kristensen AS; Kastrup JS; Pirotte B
    Eur J Med Chem; 2024 Jan; 264():116036. PubMed ID: 38101041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of positive allosteric modulators acting on AMPA receptors.
    Jin R; Clark S; Weeks AM; Dudman JT; Gouaux E; Partin KM
    J Neurosci; 2005 Sep; 25(39):9027-36. PubMed ID: 16192394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
    Raevskiĭ KS; Eremin KO
    Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
    Francotte P; Tullio Pd; Goffin E; Dintilhac G; Graindorge E; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
    J Med Chem; 2007 Jun; 50(13):3153-7. PubMed ID: 17552506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.
    Tanaka M; Kunugi A; Suzuki A; Suzuki N; Suzuki M; Kimura H
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00479. PubMed ID: 31086673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of selective AMPA receptor positive allosteric modulators.
    Ward SE; Harries M
    Curr Med Chem; 2010; 17(30):3503-13. PubMed ID: 20738249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor potentiators: application for depression and Parkinson's disease.
    O'Neill MJ; Witkin JM
    Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.
    Yamada KA
    Expert Opin Investig Drugs; 2000 Apr; 9(4):765-78. PubMed ID: 11060708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in the development of positive allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides: Introduction of (mono/difluoro)methyl groups at the 2-position of the thiadiazine ring.
    Goffin E; Fraikin P; Abboud D; de Tullio P; Beaufour C; Botez I; Hanson J; Danober L; Francotte P; Pirotte B
    Eur J Med Chem; 2023 Mar; 250():115221. PubMed ID: 36863228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
    Yamada KA
    Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA Receptors as Therapeutic Targets for Neurological Disorders.
    Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM
    Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.